Auf dieser Seite
01ORKA Preis
02Momentaufnahme
03Chart
04Aktiensplits
06Performance
07Bewertung & Kennzahlen
13Dividenden
14Erträge
15Vollständige Fundamentaldaten
16Erklärungen
17Institutionelle Eigentümer (13F)
18Aktivisten & 5%+-Eigentümer
19Unternehmensinsider
20ETF-Besitz
21Konsens
22Peers
23Nachrichten
26Meine Kennzahlen
ORKA Oruka Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 10, 2026
$84,52
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$19,0452-Wochen-Tief
$115,5252-Wochen-Hoch
Marktkapitalisierung (MRQ)
$5.16B
P/E
-9.1
EPS
$-3.87
Umsatz
$0
Ihre Abzeichen
52W-Spanne
$19–$116
Analystenbewertung
BUY
Kursziel
$155
P/E
-9.1
ROE
-25.9%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
ORKA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$84.52
Marktkapitalisierung (MRQ)
$5.16B
P/E
-9.1
EPS
$-3.87
Umsatz
$0
ROE
-25.9%
52W-Spanne
$19–$116
ORKA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 3. September 2024 | 1-for-12 | Umgekehrt |
| 4. April 2019 | 1-for-18 | Umgekehrt |
| 4. September 2015 | 1-for-7 | Umgekehrt |
| 5. März 2013 | 1-for-6 | Umgekehrt |
| 28. Januar 2009 | 1-for-20 | Umgekehrt |
| 23. Februar 2004 | 1-for-3 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$02017-12-31 → 2023-12-31
EPS$-3.872021-12-31 → 2024-12-31
Freier Cashflow$-88M2017-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | ORKA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -9.15-Jahres-Durchschnitt ≈-26.2 | ≈-26.2 | · | · | |
| K/B (MRQ) | 4.65-Jahres-Durchschnitt ≈5.7 | ≈5.7 | 9.3 | Unterbewertet | |
| Kurs / FCF (TTM) | -51.05-Jahres-Durchschnitt ≈-31.4 | ≈-31.4 | · | · | |
| Kurs / Cashflow (TTM) | -51.15-Jahres-Durchschnitt ≈-31.5 | ≈-31.5 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 8.75-Jahres-Durchschnitt ≈5.7 | ≈5.7 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | ORKA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -23.8%5-Jahres-Durchschnitt ≈-24.9% | ≈-24.9% | -22.3% | Im Einklang | |
| ROE | -25.9%5-Jahres-Durchschnitt ≈-21.7% | ≈-21.7% | -35.2% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | ORKA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 38.55-Jahres-Durchschnitt ≈37.0 | ≈37.0 | 9.6 | Starke Liquidität | |
| Quick Ratio | 21.95-Jahres-Durchschnitt ≈36.7 | ≈36.7 | 5.0 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | ORKA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$0.00 | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
| Ex-Datum | Betrag | Währung | Rendite |
|---|---|---|---|
| Aug 29, 2024 | $19,36 | USD | ≈64.5% |
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
12.9%
Nächster Bericht
Nov 10, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 17, 2026 | $-0.55 | $-0.53 | -4.6% |
| 31. März 2026 | Mai 20, 2026 | $-0.48 | $-0.56 | 14.3% |
| 31. Dezember 2025 | $-0.45 | $-0.64 | 29.7% | |
| 30. September 2025 | $-0.55 | $-0.59 | 7.3% | |
| 30. Juni 2025 | $-0.46 | $-0.50 | 8.0% | |
| 31. März 2025 | $-0.40 | $-0.52 | 22.5% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $101M | $75M | $1M | $5M | $14M | $5M | $2M | $4M | $14M | $12M | $7M | |
| SG&A Expense | $21M | $13M | $6M | $6M | $6M | $5M | $4M | $4M | $5M | $4M | $4M | |
| Operating Expenses | $122M | $88M | $7M | $11M | $19M | $10M | $6M | $8M | $19M | $17M | $11M | |
| Operating Income | $-122M | $-88M | $-7M | $-11M | $-19M | $-10M | $-6M | $-8M | $-19M | $-17M | $-11M | |
| Interest Expense | · | · | · | · | · | $9.0K | $7.0K | $8.0K | $6.0K | · | $4.0K | |
| Interest Income | $17M | $6M | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $-12.0K | $4.0K | · | · | · | · | · | · | · | · | · | |
| Pretax Income | $-105M | $-84M | · | · | $-19M | $-10M | $-6M | $-8M | $-19M | $-16M | · | |
| Income Tax | · | · | $0 | $0 | $0 | $-9.0K | $-167.0K | $-31.0K | $-61.0K | $0 | $0 | |
| Net Income | $-105M | $-84M | $-5M | $-10M | $-19M | $-10M | $-5M | $-8M | $-18M | $-16M | $-11M | |
| EPS (Basic) | · | $-3.87 | $-0.37 | $-0.69 | $-1.39 | · | · | · | · | · | · | |
| EPS (Diluted) | · | $-3.87 | $-0.37 | $-0.69 | $-1.39 | · | · | · | · | · | · | |
| Shares (Basic) | · | 16,789,362 | 14,415,877 | 14,410,143 | 13,903,871 | · | · | · | · | · | · | |
| Shares (Diluted) | · | 16,789,362 | 14,415,877 | 14,410,143 | 13,903,871 | · | · | · | · | · | · | |
| EBITDA | $-122M | $-88M | $-7M | $-11M | $-19M | $-10M | $-6M | $-8M | $-19M | $-17M | $-11M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $47M | $62M | $37M | $42M | $53M | $49M | $8M | $7M | $9M | $7M | $39M | |
| Short-term Investments | $290M | $314M | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $7M | $1M | · | · | · | · | · | · | · | · | · | |
| Other Current Assets | · | · | $161.0K | $254.0K | $1M | $897.0K | $117.0K | $169.0K | $547.0K | $282.0K | $114.0K | |
| Current Assets | $344M | $377M | $38M | $43M | $54M | $50M | $8M | $7M | $12M | $21M | $39M | |
| PP&E (Net) | $288.0K | $162.0K | $10.0K | $25.0K | $48.0K | $21.0K | $10.0K | $24.0K | $42.0K | $66.0K | $28.0K | |
| PP&E (Gross) | · | · | $222.0K | $229.0K | $243.0K | $271.0K | $377.0K | $398.0K | $443.0K | $453.0K | $415.0K | |
| Accum. Depreciation | · | · | $212.0K | $204.0K | $195.0K | $250.0K | $367.0K | $374.0K | $401.0K | $387.0K | $387.0K | |
| Other Non-current Assets | $103.0K | $43.0K | $12.0K | $18.0K | $18.0K | $12.0K | $24.0K | $24.0K | $24.0K | $766.0K | $630.0K | |
| Total Assets | $489M | $396M | $38M | $43M | $55M | $50M | $9M | $7M | $12M | $25M | $40M | |
| Accounts Payable | · | · | $362.0K | $334.0K | $1M | $2M | $418.0K | $230.0K | $622.0K | $1M | $364.0K | |
| Current Liabilities | $15M | $13M | $637.0K | $1M | $3M | $3M | $926.0K | $793.0K | $2M | $2M | $2M | |
| Capital Leases | $1M | $755.0K | $204.0K | $280.0K | $383.0K | $409.0K | · | · | · | · | · | |
| Total Liabilities | $17M | $14M | $841.0K | $1M | $4M | $4M | $926.0K | $793.0K | $2M | $2M | $2M | |
| Common Stock | $49.0K | $37.0K | $14.0K | $14.0K | $14.0K | $10.0K | $2.0K | $1.0K | $12.0K | $9.0K | $9.0K | |
| Paid-in Capital | $658M | $463M | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-189M | $-84M | $-189M | $-183M | $-173M | $-154M | $-144M | $-139M | $-131M | $-113M | $-96M | |
| AOCI | $546.0K | $-41.0K | · | · | · | · | · | · | $-2.0K | $-19.0K | · | |
| Stockholders' Equity | $472M | $382M | $37M | $42M | $51M | $47M | $8M | $6M | $10M | $22M | $38M | |
| Liabilities + Equity | $489M | $396M | $38M | $43M | $55M | $50M | $9M | $7M | $12M | $25M | $40M | |
| Shares Outstanding | 48,722,309 | 37,440,510 | 14,501,143 | 14,410,143 | 14,410,143 | 9,548,150 | 1,594,070 | 773,558 | 654,170 | 9,082,366 | 9,051,217 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $15.0K | $20.0K | $16.0K | $8.0K | $18.0K | $22.0K | $27.0K | $24.0K | $19.0K | |
| Stock-based Comp | $24M | $15M | $686.0K | $556.0K | $497.0K | $43.0K | $151.0K | $273.0K | $458.0K | $576.0K | $599.0K | |
| Operating Cash Flow | $-88M | $-58M | $-5M | $-11M | $-19M | $-8M | $-5M | $-8M | $-17M | $-15M | $-11M | |
| CapEx | $209.0K | $189.0K | $0 | $2.0K | $43.0K | $19.0K | $4.0K | $4.0K | $3.0K | $12.0K | $11.0K | |
| Investing Cash Flow | $-97M | $-330M | $0 | $-2.0K | $-43.0K | $-19.0K | $-4.0K | $3M | $13M | · | · | |
| Stock Issued | $671.0K | $54.0K | · | · | $24M | $51M | $7M | $4M | $7M | · | $37M | |
| Net Stock Activity | $671.0K | $54.0K | · | · | $24M | $51M | $7M | $4M | $7M | · | $37M | |
| Financing Cash Flow | $170M | $450M | $0 | $0 | $23M | $48M | $7M | $3M | $6M | · | · | |
| Net Change in Cash | · | · | $-5M | $-11M | $4M | $41M | $2M | $-2M | $1M | · | · | |
| Free Cash Flow | $-88M | $-58M | $-5M | $-11M | $-19M | $-8M | $-5M | $-8M | $-17M | $-15M | $-11M | |
| Levered FCF | · | · | · | · | · | $-8M | $-5M | $-8M | $-17M | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -23.8% | -42.3% | -13.2% | -20.3% | -36.7% | -33.0% | -71.4% | -82.7% | -100.0% | -51.2% | -41.1% | |
| ROE | -25.9% | -23.1% | -14.2% | -23.5% | -35.9% | -20.1% | -66.8% | -117.6% | -150.2% | -54.6% | -43.3% | |
| ROIC | · | · | · | · | · | -21.0% | -74.1% | -134.1% | -181.5% | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 22.4 | 28.9 | 59.0 | 37.7 | 15.6 | 14.3 | 9.2 | 8.5 | 5.9 | 9.0 | 25.9 | |
| Quick Ratio | 21.9 | 28.8 | 58.8 | 37.5 | 15.3 | 14.0 | 9.0 | 8.3 | 4.2 | 3.1 | 25.8 | |
| Interest Coverage | · | · | · | · | · | -1085.1 | -830.6 | -1014.8 | -3118.7 | · | -2863.8 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $9.69 | $10.21 | $2.55 | $2.89 | $3.54 | $4.87 | $4.77 | $0.43 | $0.87 | $2.44 | $4.21 | |
| Revenue / Share | · | · | $0.00 | $0.00 | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-3.44 | $-0.35 | $-0.76 | · | · | · | · | · | · | · | |
| Cash / Share | $0.96 | $1.64 | $2.58 | $2.95 | $3.70 | $5.14 | $5.25 | $0.47 | $0.74 | $0.81 | $4.29 | |
| EPS (TTM) | $-9.28 | $-3.87 | $-0.37 | $-0.69 | $-1.39 | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-105M | $-84M | $-5M | $-10M | $-19M | $-10M | $-5M | $-8M | $-18M | $-16M | $-11M | |
| Market Cap | $1.48B | $726M | $296M | $410M | $372M | $459M | $109M | $993M | $3.43B | $5.59B | $9.09B | |
| P/E | -3.3 | -5.0 | -55.1 | -41.2 | -18.6 | · | · | · | · | · | · | |
| P/B | 3.1 | 1.9 | 8.0 | 9.8 | 7.3 | 9.9 | 14.4 | 164.5 | 334.2 | 251.9 | 238.8 | |
| P / Tangible Book | 3.1 | 1.9 | 8.0 | 9.8 | 7.3 | 9.9 | · | · | · | · | · | |
| P / Cash Flow | -16.7 | -12.6 | -59.0 | -37.6 | -19.8 | -59.5 | -22.8 | -120.4 | -196.5 | -373.1 | -863.0 | |
| P / FCF | -16.7 | -12.5 | -59.0 | -37.6 | -19.8 | -59.3 | -22.7 | -120.3 | -196.5 | -372.8 | -862.1 | |
| Earnings Yield | -30.6% | -20.0% | -1.8% | -2.4% | -5.4% | · | · | · | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | |
| R&D Expense | $43M | $29M | $28M | $29M | $24M | $20M | $31M | $26M | $19M | $165.0K | $47.0K | $322.0K | $254.0K | $390.0K | $61.0K | $1M | |
| SG&A Expense | $7M | $7M | $7M | $5M | $4M | $5M | $4M | $4M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | |
| Operating Expenses | $50M | $36M | $34M | $34M | $28M | $25M | $35M | $29M | $21M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | |
| Operating Income | $-50M | $-36M | $-34M | $-34M | $-28M | $-25M | $-35M | $-29M | $-21M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | |
| Interest Income | $9M | $5M | $5M | $4M | $4M | $4M | · | $1M | · | · | · | · | · | · | · | · | |
| Other Non-op | $4.0K | $8.0K | $-12M | $4M | $-2.0K | $-5.0K | · | $826.0K | $-750.0K | · | · | · | · | · | · | · | |
| Net Income | $-41M | $-32M | $-30M | $-30M | $-25M | $-21M | $-31M | $-29M | $-22M | $-2M | $-1M | $-1M | $-1M | $-1M | $-1M | $-2M | |
| EPS (Basic) | · | · | · | · | $-0.46 | $-0.40 | · | $-1.46 | $-6.96 | $-0.14 | $-0.08 | $-0.10 | $-0.10 | $-0.09 | $-0.08 | $-0.16 | |
| EPS (Diluted) | · | · | · | · | $-0.46 | $-0.40 | · | $-1.46 | $-6.96 | $-0.14 | $-0.08 | $-0.10 | $-0.10 | $-0.09 | $-0.08 | $-0.16 | |
| Shares (Basic) | · | · | · | · | 42,095,951 | 41,679,560 | · | 15,013,655 | 3,197,975 | 14,501,143 | · | 14,410,143 | 14,410,143 | 14,410,143 | · | 14,410,143 | |
| Shares (Diluted) | · | · | · | · | 42,095,951 | 41,679,560 | · | 15,013,655 | 3,197,975 | 14,501,143 | · | 14,410,143 | 14,410,143 | 14,410,143 | · | 14,410,143 | |
| EBITDA | · | $-36M | · | $-34M | $-28M | $-25M | · | $-29M | $-3M | $-2M | · | $-2M | $-2M | $-2M | · | $-3M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $268M | $50M | $47M | $91M | $65M | $84M | $62M | $411M | $33M | $36M | $37M | $38M | $40M | $41M | $42M | $44M | |
| Short-term Investments | $605M | $339M | $290M | $258M | $263M | $266M | $314M | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $11M | $6M | $7M | $6M | $4M | $3M | $1M | $2M | · | · | · | · | · | · | · | · | |
| Other Current Assets | · | · | · | · | · | · | · | · | $537.0K | $767.0K | $161.0K | $405.0K | $599.0K | $852.0K | $254.0K | $611.0K | |
| Current Assets | $885M | $395M | $344M | $355M | $332M | $352M | $377M | $413M | $34M | $37M | $38M | $39M | $41M | $42M | $43M | $45M | |
| PP&E (Net) | $275.0K | $318.0K | $288.0K | $253.0K | $174.0K | $159.0K | $162.0K | $160.0K | $4.0K | $7.0K | $10.0K | $13.0K | $17.0K | $21.0K | $25.0K | $30.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | $222.0K | $222.0K | $222.0K | $229.0K | $229.0K | $229.0K | $229.0K | $231.0K | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | $218.0K | $215.0K | $212.0K | $216.0K | $212.0K | $208.0K | $204.0K | $201.0K | |
| Other Non-current Assets | $128.0K | $103.0K | $103.0K | $103.0K | $103.0K | $103.0K | $43.0K | $43.0K | $12.0K | $12.0K | $12.0K | $12.0K | $18.0K | $18.0K | $18.0K | $18.0K | |
| Total Assets | $1.14B | $504M | $489M | $509M | $357M | $377M | $396M | $414M | $34M | $37M | $38M | $39M | $41M | $42M | $43M | $45M | |
| Accounts Payable | · | · | · | · | · | · | · | · | $571.0K | $529.0K | $362.0K | $322.0K | $241.0K | $366.0K | $334.0K | $593.0K | |
| Current Liabilities | $23M | $17M | $15M | $21M | $12M | $12M | $13M | $18M | $1M | $2M | $637.0K | $992.0K | $2M | $1M | $1M | $2M | |
| Capital Leases | $2M | $1M | $1M | $1M | $2M | $664.0K | $755.0K | $842.0K | $0 | $0 | $204.0K | $224.0K | $243.0K | $262.0K | $280.0K | $301.0K | |
| Total Liabilities | $25M | $18M | $17M | $22M | $14M | $12M | $14M | $19M | $1M | $2M | $841.0K | $1M | $2M | $2M | $1M | $2M | |
| Common Stock | $61.0K | $50.0K | $49.0K | $48.0K | $37.0K | $37.0K | $37.0K | $35.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | |
| Paid-in Capital | $1.38B | $705M | $658M | $643M | $470M | $466M | $463M | $397M | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-262M | $-221M | $-189M | $-160M | $-129M | $-105M | $-84M | $-58M | $-193M | $-191M | $-189M | $-188M | $-186M | $-185M | $-183M | $-182M | |
| AOCI | $-2M | $-480.0K | $546.0K | $185.0K | $-27.0K | $-6.0K | $-41.0K | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $1.11B | $487M | $472M | $487M | $344M | $365M | $382M | $342M | $33M | $35M | $37M | $38M | $39M | $41M | $42M | $43M | |
| Liabilities + Equity | $1.14B | $504M | $489M | $509M | $357M | $377M | $396M | $414M | $34M | $37M | $38M | $39M | $41M | $42M | $43M | $45M | |
| Shares Outstanding | 61,069,887 | 50,167,623 | 48,722,309 | 48,384,150 | 37,450,745 | 37,440,510 | 37,440,510 | 34,998,550 | 14,507,143 | 14,501,143 | 14,501,143 | 14,410,143 | 14,410,143 | 14,410,143 | 14,410,143 | 14,410,143 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | $3.0K | $3.0K | $3.0K | $4.0K | $4.0K | $4.0K | $5.0K | $4.0K | |
| Stock-based Comp | $7M | $7M | $4M | $10M | $5M | $5M | · | $9M | $112.0K | $114.0K | $141.0K | $154.0K | $187.0K | $204.0K | $120.0K | $97.0K | |
| Operating Cash Flow | $-33M | $-24M | $-23M | $-22M | $-23M | $-21M | · | · | $-3M | $-2M | $-1M | $-2M | $-694.0K | $-2M | $-1M | $-2M | |
| CapEx | $0 | $73.0K | $63.0K | $99.0K | $34.0K | $13.0K | · | · | · | · | · | · | · | · | $0 | $0 | |
| Investing Cash Flow | $-411M | $-14M | $-22M | $-122M | $5M | $43M | · | · | $0 | $0 | · | · | $0 | $0 | $0 | $0 | |
| Stock Issued | $4M | $2M | $562.0K | $0 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $2M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $663M | $41M | $298.0K | $170M | · | · | · | · | $14.0K | $0 | · | · | $0 | $0 | · | · | |
| Net Change in Cash | · | · | · | · | · | · | · | · | $-3M | $-2M | $-1M | $-2M | $-694.0K | $-2M | $-1M | $-2M | |
| Free Cash Flow | · | $-24M | · | · | · | $-21M | · | · | · | · | · | · | · | · | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | · | -7.2% | · | -6.6% | -12.6% | -10.2% | · | -12.6% | -6.5% | -5.2% | · | -3.4% | · | -2.9% | · | -4.4% | |
| ROE | · | -7.5% | · | -7.3% | -13.1% | -10.5% | · | -15.0% | -6.9% | -5.4% | · | -3.5% | · | -3.0% | · | -4.7% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 23.8 | · | 16.9 | 27.4 | 30.0 | · | 22.9 | 26.6 | 23.2 | · | 39.2 | · | 32.9 | · | 23.0 | |
| Quick Ratio | · | 23.4 | · | 16.7 | 27.1 | 29.8 | · | 22.8 | 26.2 | 22.7 | · | 38.8 | · | 32.3 | · | 22.7 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | 0.0 | · | · | · | 0.0 | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $9.70 | · | $10.06 | $9.18 | $9.74 | · | $9.78 | $2.25 | $2.42 | · | $2.63 | · | $2.81 | · | $2.97 | |
| Revenue / Share | · | · | · | · | · | · | · | · | · | $0.00 | · | · | · | $0.00 | · | · | |
| Cash Flow / Share | · | · | · | · | · | $-0.50 | · | · | · | $-0.11 | · | · | · | $-0.11 | · | · | |
| Cash / Share | · | $0.99 | · | $1.89 | $1.75 | $2.23 | · | $11.74 | $2.29 | $2.48 | · | $2.67 | · | $2.83 | · | $3.05 | |
| EPS (TTM) | · | · | · | · | · | · | · | $-8.64 | $-7.28 | $-0.42 | · | $-0.37 | $-0.43 | $-0.55 | · | $-1.01 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income TTM | $-133M | $-116M | · | $-107M | $-105M | $-103M | · | $-54M | $-27M | $-6M | · | $-5M | $-6M | $-8M | · | $-14M | |
| Market Cap | · | $2.46B | · | $930M | $420M | $384M | · | $858M | $667M | $306M | · | $348M | · | $344M | · | $356M | |
| P/E | · | · | · | · | · | · | · | -2.8 | -6.3 | -50.3 | · | -65.2 | -56.7 | -43.4 | · | -24.5 | |
| P/B | · | 5.1 | · | 1.9 | 1.2 | 1.1 | · | 2.5 | 20.5 | 8.7 | · | 9.2 | · | 8.5 | · | 8.3 | |
| P / Tangible Book | 5.2 | 5.1 | · | 1.9 | 1.2 | 1.1 | · | 2.5 | 20.5 | 8.7 | · | 9.2 | · | 8.5 | · | 8.3 | |
| P / Cash Flow | · | -104.4 | · | · | · | -18.4 | · | · | · | -200.4 | · | · | · | -215.7 | · | · | |
| Earnings Yield | · | · | · | · | · | · | · | -35.2% | -15.8% | -2.0% | · | -1.5% | -1.8% | -2.3% | · | -4.1% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2024-02-06 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Umsatz | · | · | · | $0 | $0 |
| Nettoergebnis | $-105M | $-84M | · | $-5M | $-10M |
| Verwässerte EPS | · | $-3.87 | · | $-0.37 | $-0.69 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2024-02-06 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 22.4 | 28.9 | · | 59.0 | 37.7 |
| Quick Ratio | 21.9 | 28.8 | · | 58.8 | 37.5 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2024-02-06 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-88M | $-58M | · | $-5M | $-11M |
Institutionelle Eigentümer (13F) 263 Einreicher · $6.8B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
263
Gehaltener Wert
$6.8B
Neue Positionen
100
Geschlossene Positionen
26
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 100 (+35 vs. Vorquartal) | 26 (+8 vs. Vorquartal) | 96 (+30 vs. Vorquartal) | 47 (+18 vs. Vorquartal) | +20.8M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $862.016.075 | 9.057.645 | 12,72% | Aktien |
| BlackRock, Inc. | $474.915.526 | 4.990.181 | 7,01% | Aktien |
| Venrock Adviser, LLC | $394.805.893 | 4.148.428 | 5,83% | Aktien |
| Fairmount Funds Management LLC | $352.629.785 | 3.705.262 | 5,20% | Aktien |
| Capital World Investors | $323.733.984 | 3.401.639 | 4,78% | Aktien |
| RTW INVESTMENTS, LP | $298.741.485 | 3.139.030 | 4,41% | Aktien |
| STATE STREET CORP | $254.384.117 | 2.673.090 | 3,75% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $224.693.610 | 2.360.971 | 3,32% | Aktien |
| Paradigm Biocapital Advisors LP | $204.094.539 | 2.144.526 | 3,01% | Aktien |
| Deep Track Capital, LP | $183.297.420 | 1.926.000 | 2,70% | Aktien |
| Bellevue Group AG | $157.714.772 | 1.657.190 | 2,33% | Aktien |
| FRANKLIN RESOURCES INC | $154.313.446 | 1.621.451 | 2,28% | Aktien |
| Remedium Capital Partners, LLC | $149.003.957 | 1.565.661 | 2,20% | Aktien |
| RA CAPITAL MANAGEMENT, L.P. | $147.950.996 | 1.554.597 | 2,18% | Aktien |
| VIKING GLOBAL INVESTORS LP | $143.086.001 | 1.503.478 | 2,11% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $136.113.846 | 1.429.954 | 2,01% | Aktien |
| PERCEPTIVE ADVISORS LLC | $128.009.646 | 1.345.063 | 1,89% | Aktien |
| Polar Capital Holdings Plc | $116.926.719 | 1.228.609 | 1,73% | Aktien |
| CITADEL ADVISORS LLC | $106.496.277 | 1.119.011 | 1,57% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $102.689.858 | 1.079.015 | 1,52% | Aktien |
| VANGUARD GROUP INC | $74.366.494 | 2.453.530 | 1,10% | Aktien |
| Avidity Partners Management LP | $72.369.552 | 760.424 | 1,07% | Aktien |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | $62.650.506 | 658.301 | 0,92% | Aktien |
| Aberdeen Group plc | $61.569.565 | 646.943 | 0,91% | Aktien |
| UBS Group AG | $60.848.177 | 639.363 | 0,90% | Aktien |
| JPMORGAN CHASE & CO | $60.736.334 | 655.027 | 0,90% | Aktien |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $60.093.479 | 631.433 | 0,89% | Aktien |
| Pictet Asset Management Holding SA | $58.914.871 | 619.076 | 0,87% | Aktien |
| Affinity Asset Advisors, LLC | $56.150.300 | 590.000 | 0,83% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $55.427.865 | 582.409 | 0,82% | Aktien |
| Cormorant Asset Management, LP | $50.757.968 | 533.340 | 0,75% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $41.247.154 | 433.405 | 0,61% | Aktien |
| NORTHERN TRUST CORP | $40.817.558 | 428.891 | 0,60% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $38.177.350 | 401.149 | 0,56% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $34.797.007 | 365.630 | 0,51% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $34.651.587 | 364.102 | 0,51% | Aktien |
| Synergy Asset Management, LLC | $33.909.166 | 356.301 | 0,50% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $33.785.636 | 355.003 | 0,50% | Aktien |
| BANK OF AMERICA CORP /DE/ | $33.578.260 | 352.824 | 0,50% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $33.576.166 | 352.802 | 0,50% | Aktien |
| Candriam S.C.A. | $33.535.685 | 352.716 | 0,49% | Aktien |
| Holocene Advisors, LP | $29.117.357 | 305.951 | 0,43% | Aktien |
| JENNISON ASSOCIATES LLC | $28.480.289 | 299.257 | 0,42% | Aktien |
| Woodline Partners LP | $27.146.957 | 285.247 | 0,40% | Aktien |
| BRAIDWELL LP | $26.472.868 | 278.164 | 0,39% | Aktien |
| Siren, L.L.C. | $23.792.500 | 250.000 | 0,35% | Aktien |
| Nuveen, LLC | $23.722.741 | 249.267 | 0,35% | Aktien |
| EVENTIDE ASSET MANAGEMENT, LLC | $22.840.800 | 240.000 | 0,34% | Aktien |
| Blackstone Inc. | $22.565.568 | 237.108 | 0,33% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $20.846.000 | 219.039 | 0,31% | Aktien |
Aktivisten & 5%+-Eigentümer 9 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Fairmount Healthcare Co-Invest III L.P., Harwin Peter Evan, Kiselak Tomas ×7 Einreichungen | 1. Juli 2026 | 19,50% | Änderung | · | SEC |
| Adage Capital Management, L.P., Robert Atchinson, Phillip Gross ×2 Einreichungen | 22. Oktober 2024 | · | Erste Einreichung | · | SEC |
| Funicular Funds, LP, The Funicular Fund, LP, Jacob Ma-Weaver | 8. Juli 2022 | · | Erste Einreichung | · | SEC |
| The Funicular Fund, LP, Jacob Ma-Weaver ×6 Einreichungen | 21. Juni 2022 | · | Erste Einreichung | · | SEC |
| 5. März 2018 | · | Erste Einreichung | · | SEC | |
| Growth Equity Opportunities Fund IV, LLC, New Enterprise Associates 15, L.P., NEA Partners 15, L.P., NEA 15 GP, LLC, Peter J. Barris, Forest Baskett, Anthony A. Florence, Jr., Krishna S. Kolluri, Joshua Makower, David M. Mott, Jon M. Sakoda, Scott D. Sandell, Peter W. Sonsini, Ravi Viswanathan, Harry R. Weller | 29. Juni 2015 | · | Erste Einreichung | Passive Anlage | SEC |
| Atlas Venture Fund VII, L.P., Atlas Venture Associates VII, L.P. | 2. November 2012 | · | Erste Einreichung | · | SEC |
| Credit Suisse, on behalf of the Investment Banking division | 15. März 2006 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 6. April 2004 | · | Erste Einreichung | Vorstandskampagne | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 61 Insider · 18 Führungskräfte · 28 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Lawrence Otto Klein | Chief Executive Officer | 1. Oktober 2026 M | 923.128 | 0 | 9 | $-9.405.009 |
| Jeffrey C. Dekker | Chief Financial Officer | 8. Dezember 2022 A | 40.000 | 0 | 0 | $0 |
| Patrick M Wheeler | Chief Financial Officer | 18. September 2014 S | 101.510 | 0 | 0 | $0 |
| Kathryn E Falberg | CFO and COO | 25. Juni 2009 A | 0 | 0 | 0 | $0 |
| Lee E Bendekgey | Sr. VP CFO and General Counsel | 1. Februar 2008 A | 6.511 | 0 | 0 | $0 |
| Henry Ward Wolff | Sr. VP Finance and CFO | 1. Februar 2007 A | 229 | 0 | 0 | $0 |
| Laura Lee Sandler | Chief Operating Officer | 15. September 2026 S | 235.478 | 0 | 19 | $-1.942.513 |
| Thomas A Keuer | Chief Operating Officer | 8. Dezember 2022 A | 40.730 | 0 | 0 | $0 |
| Arjun Agarwal | Senior Vice President, Finance | 21. September 2026 S | 14.219 | 0 | 26 | $-4.329.391 |
| Paul T Quinlan | General Counsel | 21. September 2026 M | 29.995 | 0 | 13 | $-6.758.520 |
| Joana Goncalves | Chief Medical Officer | 15. September 2026 M | 31.771 | 0 | 35 | $-4.543.414 |
| Larry Todd Edwards | Chief Commercial Officer | 24. August 2026 A | 100.000 | 0 | 0 | $0 |
| Michael R Bristow | Pres. & Chief Executive Offic | 14. Dezember 2021 A | 41.155 | 0 | 0 | $0 |
| Brian L. Selby | VP, Finance | 21. Dezember 2020 A | 0 | 0 | 0 | $0 |
| Michael D Levy | Executive Vice President | 1. Februar 2008 A | 20.821 | 0 | 0 | $0 |
| Gary Titus | Chief Acct.Officer | 30. August 2006 S | 2.633 | 0 | 0 | $0 |
| Peter S Garcia | Senior V.P. and C.F.O. | 7. Mai 2004 A | · | 0 | 0 | $0 |
| Linda A Fitzpatrick | Senior V.P. of Human Resources | 7. Mai 2004 A | · | 0 | 0 | $0 |
| Carl Dambkowski | Direktor | 12. Juni 2026 S | 38.743 | 0 | 5 | $-8.645.640 |
| Christopher Nathan Martin | Direktor | 2. Juni 2026 A | · | 0 | 0 | $0 |
| Samarth Kulkarni | Direktor | 2. Juni 2026 A | · | 0 | 0 | $0 |
| Kristine M Ball | Direktor | 2. Juni 2026 A | · | 0 | 0 | $0 |
| Cameron Turtle | Direktor | 2. Juni 2025 A | · | 0 | 0 | $0 |
| Flynn James P. | Direktor | 30. Januar 2024 A | · | 0 | 0 | $0 |
| Raymond L. Woosley | Direktor | 30. Januar 2024 A | · | 0 | 0 | $0 |
| Linda S Grais | Direktor | 30. Januar 2024 A | 491.889 | 0 | 0 | $0 |
| Anders D Hove | Direktor | 30. Januar 2024 A | · | 0 | 0 | $0 |
| Robert E Conway | Direktor | 30. Januar 2024 A | 50.000 | 0 | 0 | $0 |
| Daniel J Mitchell | Direktor | 30. Januar 2024 A | 11.000 | 0 | 0 | $0 |
| ZABRISKIE JOHN L | Direktor | 17. September 2013 A | 156.131 | 0 | 0 | $0 |
| FORMELA JEAN FRANCOIS | Direktor | 22. Oktober 2012 A | 1.579.542 | 0 | 0 | $0 |
| Burton E Sobel | Direktor | 10. Februar 2012 A | 0 | 0 | 0 | $0 |
| Richard B Brewer | Direktor | 10. Februar 2012 A | · | 0 | 0 | $0 |
| William J Freytag | Direktor | 5. Februar 2010 A | · | 0 | 0 | $0 |
| Mary K Pendergast | Direktor | 5. Februar 2010 A | 2.000 | 0 | 0 | $0 |
| Ted W Love | Direktor | 5. Februar 2010 A | 57.289 | 0 | 0 | $0 |
| David George Lowe | Direktor | 21. Juli 2009 S | 129.600 | 0 | 0 | $0 |
| Kimberly J Popovits | Direktor | 4. Juni 2008 A | · | 0 | 0 | $0 |
| James R Gavin III | Direktor | 4. Juni 2008 A | · | 0 | 0 | $0 |
| Mark L Perry | Direktor | 4. Juni 2008 A | 65.833 | 0 | 0 | $0 |
| Barry L Zubrow | Direktor | 31. Mai 2007 A | 50.000 | 0 | 0 | $0 |
| George B Rathmann | Direktor | 24. Mai 2005 A | 903.788 | 0 | 0 | $0 |
| Philippe Chambon | Direktor | 6. Mai 2004 A | 5.759.875 | 0 | 0 | $0 |
| Carter Iii Thomas N Mc | Direktor | 27. März 2003 A | · | 0 | 0 | $0 |
| Funicular Funds, LP | 10%-Eigentümer | 1. Juli 2022 J | 2.580.452 | 0 | 0 | $0 |
| Jon Sakoda | 10%-Eigentümer | 26. Februar 2018 S | 0 | 0 | 0 | $0 |
| Anthony A. Florence, Jr. | 10%-Eigentümer | 26. Februar 2018 S | 0 | 0 | 0 | $0 |
| Peter W. Sonsini | 10%-Eigentümer | 26. Februar 2018 S | 0 | 0 | 0 | $0 |
| Ravi Viswanathan | 10%-Eigentümer | 26. Februar 2018 S | 0 | 0 | 0 | $0 |
| Forest Baskett | 10%-Eigentümer | 26. Februar 2018 S | 0 | 0 | 0 | $0 |
| Scott D. Sandell | 10%-Eigentümer | 26. Februar 2018 S | 0 | 0 | 0 | $0 |
| Joshua Makower | 10%-Eigentümer | 26. Februar 2018 S | 0 | 0 | 0 | $0 |
| David M Mott | 10%-Eigentümer | 26. Februar 2018 S | 0 | 0 | 0 | $0 |
| Peter J Barris | 10%-Eigentümer | 26. Februar 2018 S | 0 | 0 | 0 | $0 |
| mccormack riley | 10%-Eigentümer | 16. Januar 2015 S | 2.100.000 | 0 | 0 | $0 |
| Atlas Venture Fund VII L P | 10%-Eigentümer | 29. März 2010 S | 1.337.612 | 0 | 0 | $0 |
| Ma-Weaver Jacob | · | 29. August 2024 J | · | 0 | 0 | $0 |
| Funicular Fund, LP | · | 4. April 2022 P | 1.944.993 | 0 | 0 | $0 |
| Christopher David Ozeroff | · | 14. Dezember 2021 A | 50.970 | 0 | 0 | $0 |
| Skyline Venture Partners Qualified Purchaser Fund IV L P | · | 15. Juni 2009 S | 335.400 | 0 | 0 | $0 |
| CREDIT SUISSE/ | · | 30. Juli 2004 C | 7.230 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 33 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| DWAS · Invesco Exchange-Traded Fund Trust … | 1,24% | 60.400 SH | 2. Oktober 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 1,03% | 52.700 NS | 31. Juli 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,93% | 4.447 NS | 31. Juli 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 0,76% | 28.596 NS | 31. Juli 2026 | N-PORT |
| JSMD · Janus Detroit Street Trust | 0,75% | 82.097 NS | 31. Juli 2026 | N-PORT |
| MEDI · Harbor ETF Trust | 0,60% | 2.546 NS | 31. Juli 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,37% | 4.675 SH | 2. Oktober 2026 | Täglich |
| IBB · iShares Trust | 0,34% | 387.461 SH | 11. September 2026 | Täglich |
| IWO · iShares Trust | 0,30% | 474.512 SH | 11. September 2026 | Täglich |
| PWS · Pacer Funds Trust | 0,29% | 720 NS | 31. Juli 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,28% | 53.886 SH | 19. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,21% | 43.678 SH | 19. August 2026 | Täglich |
| BKSE · BNY Mellon ETF Trust | 0,18% | 1.613 NS | 31. Juli 2026 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0,17% | 26.725 NS | 31. Juli 2026 | N-PORT |
| RSSL · Global X Funds | 0,16% | 24.116 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,15% | 1.290.256 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,15% | 289.905 SH | 19. August 2026 | Täglich |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,13% | 9.664 NS | 31. Juli 2026 | N-PORT |
| ESML · iShares Trust | 0,08% | 23.234 SH | 11. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,05% | 580.805 SH | 19. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,04% | 14.937 NS | 31. Juli 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,04% | 94.538 SH | 19. August 2026 | Täglich |
| WSML · iShares Trust | 0,03% | 2.436 SH | 11. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,03% | 42.314 NS | 31. Juli 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 6.687 SH | 2. Oktober 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 1.725.048 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 4.138 SH | 19. August 2026 | Täglich |
| ITOT · iShares Trust | 0,01% | 68.259 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,01% | 13.545 SH | 11. September 2026 | Täglich |
| PTH · Invesco Exchange-Traded Fund Trust | 0,00% | 72 SH | 2. Oktober 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 1.553 NS | 31. Juli 2026 | N-PORT |
| ISCB · iShares Trust | · | 1.604 SH | 11. September 2026 | Täglich |
| SMMV · iShares Trust | · | 1.959 SH | 1. September 2026 | Täglich |
ORKA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 20 Analysten
KAUF
Median-Ziel
$155.50
+84,0%
9 45,0%
Starker Kauf
10 50,0%
Kauf
1 5,0%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
12 Analysten · 2026-09-28Mittelwert-Ziel $155.00 +83,4%
← Unter allen Zielen
Aktueller Preis $84.52
Tief$117.00
Mittelwert$155.00
Hoch$200.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ORKA | $1.48B | -3.3 | · | · | -25.9% | · |
| RYTM | $7.19B | -34.4 | 45.8% | -103.6% | -309.1% | · |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | · |
| KOD | $1.73B | -6.5 | · | · | -202.0% | · |
| CGON | $3.35B | -20.0 | 254.7% | -3985.0% | -22.6% | · |
| SRRK | $4.78B | -13.4 | · | · | -157.9% | · |
| COGT | $5.72B | -16.4 | · | · | -83.1% | · |
| MIRM | $4.10B | -168.1 | 54.7% | -4.5% | -8.2% | · |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | · |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | · |
| ERAS | $1.06B | -8.5 | · | · | -35.7% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 10, 2026